Clinical Trial Update: Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an anti-HER2 therapy in HER2-positive metastatic cancers of the digestive system; status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Colorectal Cancer
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shen Lin | Conditions: Targeted Therapy, HER2 | Phase 2 | Status: UNKNOWN